Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Store lyophilized Tirzepatide 30mg at -20C for long-term stability
There is also an ongoing cardiovascular outcomes trial of tirzepatide (SURPASS-CVOT) in individuals with type 2 diabetes and cardiovascular disease [91], which, if successful, will broaden the use of tirzepatide to those with manifest or increased risk for CVD, as is the case for GLP-1 receptor agonists [22]
Also fasting plasma glucose levels decreased significantly by 16.7% compared to baseline and by 18.4% compared to placebo
The amount of time someone takes a GLP-1 medication should be determined by their health care provider
US$ 29.12
US$ 28.64
US$ 22.42
